This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.
RSA 326-B:1 · Purpose
326-B:1 Purpose. – In order to safeguard the life, health, and public welfare of the people of New Hampshire and in order to protect the people of the state from the unauthorized, unqualified, and improper application of services by individuals in the practice of nursing, it is necessary that a regulatory authority be established and adequately funded. To further this policy, the practice of nursing shall be regulated through the New Hampshire board of nursing, and such board shall have the power to enforce the provisions of this chapter. Licensees under this chapter are accountable to clients, the nursing profession, and the board for complying with the requirements of this act and the quality of nursing care rendered, and for recognizing limits of knowledge and experience and planning for management of situations beyond the licensee's experience. Source. 2005, 293:1, eff. July 1, 2005 at 12:01 a.m.
Copy linkSource note
Source. 2005, 293:1, eff. July 1, 2005 at 12:01 a.m.
Source history
- 2005, 293:1, eff. July 1, 2005 at 12:01 a.m
Related materials
Bill relationships
-
2026 HB1030
amend
ical nurse scope of practice. Be it Enacted by the Senate and House of Representatives in General Court convened: 46:1 Scope of Practice; Licensed Practical Nurse. Amend RSA 326-B:13, I(a)-(c) to read as follows: (a) Collecting data and conducting [focused] nursing assessments to contribute to the comprehensive assessment of the health status of assigned clients. (b) Planning nursing care for
-
2026 HB1321
reference
cian licensed under this chapter, a physician associate licensed under RSA 328-D acting within the scope of their practice, or an advanced practice registered nurse licensed under RSA 326-B acting within the scope of their practice. 329:56 Administration of Elective Intravenous Therapy. Elective intravenous therapy may only be administered by a physician licensed under this chapter, a physician associ
-
2026 HB1796
reference · effective 2027-01-01
rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic
-
2026 HB1796-FN
reference · effective 2027-01-01
rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic
-
2026 HB470
reference
(ADA). (g) The requirement that the physical presence of the dentist licensed under RSA 317-A:7, an anesthesiologist licensed under RSA 329, or a nurse anesthetist licensed under RSA 326-B:18 is required while general anesthesia, deep sedation or moderate sedation is in effect. (h) The establishment of the qualifications of dentists to administer general anesthesia or deep sedation, which may include a resi
-
2026 SB453
reference
d by the commissioner or his designee shall be for a period not to exceed 2 years; except in any case where a licensed physician, advanced practice registered nurse licensed under RSA 326-B, or physician associate licensed under RSA 329-D documents a lasting medical necessity, in which case the waiver shall be for a period not to exceed 4 years. The applicant may reapply for the waiver before such period e
-
2025 HB254
reference
tions to be used in medical aid in dying: (1) A physician licensed pursuant to RSA 329; (2) An osteopathic physician licensed pursuant to RSA 329; (3) An advanced practice registered nurse licensed pursuant to RSA 326-B; or (4) A pharmacist licensed pursuant to RSA 318; provided, however, that a pharmacist shall not qualify as an attending health care provider under RSA 137-M:1, II or as a consulting health care provider unde
Opinions and discipline decisions mentioning this RSA
- 2025 N.H. 33, State v. Allore Supreme Court opinion · July 30, 2025